Correlation Between Soleno Therapeutics and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Eli Lilly and, you can compare the effects of market volatilities on Soleno Therapeutics and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Eli Lilly.

Diversification Opportunities for Soleno Therapeutics and Eli Lilly

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Soleno and Eli is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Eli Lilly go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Eli Lilly

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.93 times more return on investment than Eli Lilly. However, Soleno Therapeutics is 1.07 times less risky than Eli Lilly. It trades about 0.1 of its potential returns per unit of risk. Eli Lilly and is currently generating about -0.19 per unit of risk. If you would invest  5,531  in Soleno Therapeutics on August 29, 2024 and sell it today you would earn a total of  303.00  from holding Soleno Therapeutics or generate 5.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Soleno Therapeutics  vs.  Eli Lilly and

 Performance 
       Timeline  
Soleno Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Soleno Therapeutics and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Soleno Therapeutics and Eli Lilly

The main advantage of trading using opposite Soleno Therapeutics and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Soleno Therapeutics and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities